Home / Expertise / Corporate Crime, Compliance & Forensics
Corporate Crime

Corporate Crime, Compliance & Forensics

International

In an enforcement environment that is constantly evolving, our specialist teams around the world assist clients with all aspects of corporate crime, compliance and forensics. This includes:

  • developing controls to prevent wrongdoing occurring in your business
  • understanding and navigating the legal issues and risks when allegations or concerns arise
  • conducting legally defensible and (where available) legally privileged investigations, while recognising the wider risks and obligations created by the issue at hand.

Our global team of over 400 expert lawyers regularly advises corporates and individuals on financial crime and all other areas of criminal and regulatory risk (be it competition, cyber, environmental, health and safety or otherwise) across multiple jurisdictions.

Their years of experience means they can assist clients to develop effective responses to regulators, prosecutors, customers, employees and other key stakeholders during a crisis.

Whether you want a strategy to avoid regulatory investigations, or a way to minimise the impact of unforeseen corporate crime or regulatory failure, we will provide you with clear and pragmatic advice tailored to your needs.

Corporate Crime

We work to safeguard our clients’ businesses to resolve issues quickly and effectively with minimal reputational harm.  We help our clients to demonstrate a robust and defensible position to regulators and prosecutors.

Compliance

We help clients to develop a robust governance framework and to implement appropriate and risk-based improvements to compliance systems and controls, consistent with market best practice and regulatory expectations. We regularly advise on global and local controls, often providing advice across multiple jurisdictions and legal regimes to help give clients comfort that their controls meet local requirements.  This work includes risk assessments, due diligence, data collection procedures, crisis management and investigation plans, appropriate governance controls (policies and procedures) and aligning your finance and risk functions.

Forensics

We are your single point of contact, to detect, investigate and resolve wrongdoing. We have market-leading forensic tools to gather, host and review data sources to uncover the facts under investigation efficiently and thoroughly.  Our teams also help clients to navigate the pitfalls of legal privilege/ professional secret, data protection, data transfer and employment, as well as positive reporting obligations, all of which can expose businesses to greater risk if not handled correctly from the outset.

Read more Read less
15 May 2020
CMS Ex­pert Guide to COV­ID-19 cor­por­ate crime & reg­u­lat­ory is­sues
The COV­ID-19 lock­down will not last forever. Op­er­at­ing both dur­ing and bey­ond the lock­down could throw up nov­el and un­ex­pec­ted cor­por­ate crime and li­ab­il­ity risks for busi­nesses. Re­sum­ing or in­creas­ing busi­ness op­er­a­tions as re­stric­tions ease will en
June 2018
CMS Guide to Anti-Bribery and Cor­rup­tion Laws 2018
We are de­lighted to present the fifth edi­tion of the CMS Guide to Anti-Bribery and Cor­rup­tion Laws.This edi­tion of the Guide cov­ers more coun­tries than ever be­fore, as­sess­ing the laws in 42 coun­tries...
CMS Dawn Raid App

Feed

Show only
14 January 2021
Belt and Road videocasts
Go to BRI homepage Wel­come to the CMS videocasts on Belt and Road The series ex­plores the top­ics that have been iden­ti­fied in our glob­al re­search study as be­ing top of mind for par­ti­cipants in BRI pro­jects...
13 November 2020
BRI - View from CEE
China’s Belt and Road ini­ti­at­ive has the po­ten­tial to help na­tions across Cent­ral and East­ern Europe meet their di­verse and grow­ing in­fra­struc­ture needs. Nearly every coun­try in the re­gion has signed a Belt and Road agree­ment with China, and most are on the trade routes that China plans to en­hance. But after ini­tial op­tim­ism the re­gion has lagged be­hind oth­ers in de­vel­op­ing Belt and Road pro­jects, with vari­ous polit­ic­al, eco­nom­ic and op­er­a­tion­al is­sues slow­ing pro­gress.The latest in a series of Belt and Road re­ports from CMS ex­am­ines the sen­ti­ment in the re­gion to­wards BRI, the chal­lenges that ex­ist, and the steps Belt and Road par­ti­cipants can take to achieve suc­cess. ht­tp://view.cer­os.com/cms-em­bed/bri-cee-sec­tor-high­lights/p/1750560left­fal­seTop­ics covered in the re­port in­clude:Belt and Road 2.0 – a more sus­tain­able ap­proach to de­vel­op­mentThe sec­tors at­tract­ing most in­terest among Belt and Road par­ti­cipant­sThe ef­fects of Cov­id-19 on Belt and Ro­ad­Mit­ig­at­ing Belt and Road risk and man­aging dis­pute­sAs well as look­ing at Belt and Road across CEE, we ex­am­ine at its im­pact to date in Ukraine and Rus­sia, and their po­ten­tial for fu­ture in­vest­ment.
28 September 2020
BRI - View from China
The Belt and Road Ini­ti­at­ive (BRI) con­tin­ues to evolve. Its par­ti­cipants are in­creas­ingly look­ing to meet the trends of the fu­ture. Af­ford­able pro­jects, em­bra­cing mod­ern tech­no­lo­gies and meth­ods, as well the “open, green and clean” ap­proach of BRI 2.0, will of­ten be those that stand the greatest chance of suc­cess – a point un­der­lined by China’s re­cently an­nounced tar­get for car­bon neut­ral­ity and Pres­id­ent Xi Jin­ping’s call for a green re­cov­ery of the world eco­nomy.But how are the un­pre­ced­en­ted dif­fi­culties of 2020, in­clud­ing the glob­al pan­dem­ic and trade dis­putes, af­fect­ing the pro­spects of BRI?Wel­come to the first of a series of re­ports that as­sess the chal­lenges for BRI and the steps that BRI par­ti­cipants can take to achieve both suc­cess for them­selves and a pos­it­ive fu­ture for BRI. This re­port is in­ten­ded primar­ily for a Chinese read­er­ship and is there­fore avail­able in both Eng­lish and Chinese.The re­port ex­am­ines:Why Chinese par­ti­cipants in BRI are more gen­er­ally pos­it­ive about it than non-Chinese par­ti­cipants, and how this may be re­solved.The ef­fects of Cov­id-19 on BRI, and new en­thu­si­asm for the Health Silk Road.How to mit­ig­ate BRI risk and man­age dis­putes.Po­ten­tial trends in the fin­an­cing of BRI pro­jects.The im­pact of BRI 2.0.
31 July 2020
An­nu­al Re­view 2019 – 2020
We are liv­ing in tur­bu­lent times, char­ac­ter­ised by polit­ic­al, cli­mate and health crises. The most acute of these – the COV­ID-19 pan­dem­ic – has clearly shown how in­ter­con­nec­ted our eco­nom­ies are: travel, com­merce and sup­ply chains world­wide have been im­pacted. No in­di­vidu­al or busi­ness has re­mained totally un­af­fected by it.As a glob­al or­gan­isa­tion, with a pres­ence in key busi­ness hubs around the world, we are wit­ness­ing the im­pact of the pan­dem­ic firsthand. Our teams in Asia, Europe, Africa and Lat­in Amer­ica are help­ing cli­ents deal with this un­pre­ced­en­ted situ­ation. Un­fold­ing in dif­fer­ent in­tens­it­ies in dif­fer­ent parts of the world at dif­fer­ent times, our teams are in the for­tu­nate po­s­i­tion of be­ing able to con­nect with and learn from each oth­er. This en­ables us to sup­port our cli­ents in a mean­ing­ful way, listen­ing to and un­der­stand­ing their con­cerns and provid­ing them with busi­ness-rel­ev­ant ad­vice that draws on in­sights from our ex­perts world­wide.In this crisis, we, as a so­ci­ety, are at a cross­roads. What is cer­tain is that for in­di­vidu­als and busi­nesses (ours in­cluded) there will be no ‘back to busi­ness as usu­al’. Things need to (and will) change. How we shape the ‘new nor­mal’ is up to us. In this An­nu­al Re­view, we look at some key de­vel­op­ments that are in­creas­ingly im­pact­ing busi­ness suc­cess. Com­pan­ies need to take these in­to con­sid­er­a­tion when ad­apt­ing their op­er­a­tions to the new busi­ness en­vir­on­ment.The months ahead will be chal­len­ging for us all. Busi­nesses will need to think stra­tegic­ally and po­s­i­tion them­selves for suc­cess in the new nor­mal. We at CMS see it as our task to guide our cli­ents through this chan­ging busi­ness land­scape.Mat­thi­as Licht­blau (Ex­ec­ut­ive Dir­ect­or) Pierre-Sé­bas­tien Thill (Chair­man) Duncan We­st­on (Ex­ec­ut­ive Part­ner) CMS Ex­ec­ut­ive Team
03 June 2020
The Ver­dict: Spring/Sum­mer 2020 Edi­tion
Wel­come to the Spring/Sum­mer 2020 edi­tion of the Ver­dict, an at-a-glance round-up of re­cent leg­al de­vel­op­ments in re­la­tion to cor­por­ate crime.In this is­sue, the spot­light is on the over­haul of crim­in­al...
08 June 2020
Crim­in­al and ad­min­is­trat­ive li­ab­il­ity risks for busi­nesses arising from...
Re­sum­ing busi­ness as lock­downs are eased around the world could throw up nov­el and un­ex­pec­ted cor­por­ate crime and li­ab­il­ity risks for busi­nesses and their seni­or man­age­ment. A re­sump­tion plan ad­dress­ing...
15 May 2020
CMS Ex­pert Guide to COV­ID-19 cor­por­ate crime & reg­u­lat­ory is­sues
The COV­ID-19 lock­down will not last forever. Op­er­at­ing both dur­ing and bey­ond the lock­down could throw up nov­el and un­ex­pec­ted cor­por­ate crime and li­ab­il­ity risks for busi­nesses. Re­sum­ing or in­creas­ing...
27 October 2019
ACC 2019 An­nu­al Meet­ing
CMS - Meet our ex­perts More than 70 per­cent of the world’s pur­chas­ing power is loc­ated out­side of the United States. So for US com­pan­ies, es­tab­lish­ing or grow­ing their busi­ness and in­vest­ments with...
15 July 2019
CMS ad­vised Col­gate-Pal­molive on ac­quis­i­tion of Labor­atoires Filorga Cos­métiques
A CMS team cov­er­ing 11 jur­is­dic­tions, to­geth­er with Col­gate's US ad­visers, ad­vised Col­gate-Pal­molive in its ca. EUR 1.5bn ac­quis­i­tion of Labor­atoires Filorga Cos­métiques.Ori­gin­ally foun­ded in France...